Editorial ArticleHow do point of care high-sensitivity tests compare to lab-based assays for acute coronary syndrome diagnosis?
Industry NewsFerrer announces first patient enrollment of FNP122 in ADORE Phase III trial for ALS treatment
Industry NewsResearchers discover a new tool that uses high-powered lasers to help improve cancer treatment
Industry NewsNew sub-analyses further support consistency of Farxiga’s cardiorenal and mortality benefits
Editorial ArticleTherapeutic antibodies: Advancing the development of COVID-19 neutralizing antibodies